Manufacturer of Controlled Substances; Notice of Application, 39127-39128 [2011-16794]
Download as PDF
<![CDATA[
39127
Federal Register / Vol. 76, No. 128 / Tuesday, July 5, 2011 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on May 16, 2011,
Cayman Chemical Company, 1180 East
Ellsworth Road, Ann Arbor, Michigan
48108, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
srobinson on DSK4SPTVN1PROD with NOTICES
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N-N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
1-Pentyl-3-(1-naphthoyl)indole (7118) .........................................................................................................................................................
1-Butyl-3-(1-naphthoyl)indole (7173) ...........................................................................................................................................................
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) Indole (7200) .............................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
5-(1,1-Dimethulheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7297) .....................................................................................................
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7298) ........................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ...............................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine (7401) ..................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine (7431) .................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Lisdexamfetamine (1205) ............................................................................................................................................................................
The company plans to manufacture
small quantities of marihuana
derivatives for research purposes. In
reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidol. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
will manufacture a synthetic THC. No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
VerDate Mar<15>2010
17:58 Jul 01, 2011
Jkt 223001
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 6, 2011.
Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–16791 Filed 7–1–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 13, 2011,
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
Johnson Matthey Pharmaceutical
Materials Inc., Pharmaceutical Service,
25 Patton Road, Devens, Massachusetts
01434, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Remifentanil (9739) the
basic class of controlled substance in
schedule II.
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
E:\FR\FM\05JYN1.SGM
05JYN1
39128
Federal Register / Vol. 76, No. 128 / Tuesday, July 5, 2011 / Notices
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 6, 2011.
Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
[FR Doc. 2011–16794 Filed 7–1–11; 8:45 am]
Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
[FR Doc. 2011–16799 Filed 7–1–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated February 15, 2011,
and published in the Federal Register
on February 23, 2011, 76 FR 10068,
Johnson Matthey Pharmaceutical
Materials Inc., Pharmaceutical Service,
25 Patton Road, Devens, Massachusetts
01434, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
srobinson on DSK4SPTVN1PROD with NOTICES
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Nabilone (7379) ............................
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Hydrocodone (9193) .....................
II
II
II
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
VerDate Mar<15>2010
17:58 Jul 01, 2011
Jkt 223001
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated March 8, 2011, and
published in the Federal Register on
March 17, 2011, 76 FR 14690, Cambrex
Charles City, Inc., 1205 11th Street,
Charles City, Iowa 50616, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
4-Anilino-N-phenethyl-4-piperdine
(8333), a basic class of controlled
substance listed in schedule II.
The company plans to use this
controlled substance in the manufacture
of another controlled substance.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambrex Charles City, Inc. to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Cambrex Charles City, Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Dated: June 27, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–16801 Filed 7–1–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
United States Parole Commission
Record of Vote of Meeting Closure
(Pub. L. 94–409) (5 U.S.C. 552b)
I, Isaac Fulwood, of the United States
Parole Commission, was present at a
meeting of said Commission, which
started at approximately 11 a.m., on
Tuesday, June 21, 2011, at the U.S.
Parole Commission, 90 K Street, NE.,
Third Floor, Washington, DC 20530.
The purpose of the meeting was to
discuss three original jurisdiction cases
pursuant to 28 CFR 2.27. Four
Commissioners were present,
constituting a quorum when the vote to
close the meeting was submitted.
Public announcement further
describing the subject matter of the
meeting and certifications of the General
Counsel that this meeting may be closed
by votes of the Commissioners present
were submitted to the Commissioners
prior to the conduct of any other
business. Upon motion duly made,
seconded, and carried, the following
Commissioners voted that the meeting
be closed: Isaac Fulwood, Cranston J.
Mitchell, Patricia Cushwa and J. Patricia
Wilson Smoot.
In witness whereof, I make this official
record of the vote taken to close this
meeting and authorize this record to be
made available to the public.
Dated: June 21, 2011.
Isaac Fulwood,
Chairman, U.S. Parole Commission.
[FR Doc. 2011–16563 Filed 7–1–11; 8:45 am]
BILLING CODE 4410–01–M
DEPARTMENT OF LABOR
Comment Request for Information
Collection for the Trade Adjustment
Assistance Community College and
Career Training (TAACCCT) Grant
Program, New Collection
Employment and Training
Administration, Labor.
ACTION: Notice.
AGENCY:
The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
SUMMARY:
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 76, Number 128 (Tuesday, July 5, 2011)]
[Notices]
[Pages 39127-39128]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16794]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 13, 2011, Johnson
Matthey Pharmaceutical Materials Inc., Pharmaceutical Service, 25
Patton Road, Devens, Massachusetts 01434, made application by letter to
the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of Remifentanil (9739) the basic class of controlled
substance in schedule II.
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to the
company's customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances,
[[Page 39128]]
may file comments or objections to the issuance of the proposed
registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than September 6, 2011.
Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-16794 Filed 7-1-11; 8:45 am]
BILLING CODE 4410-09-P
